Part 4/7:
The closures have drawn attention to larger economic issues, particularly the effects of recent legislation like the Inflation Reduction Act. Critics argue that increased government regulation and pressures on pharmaceutical pricing have strained Walgreens and other pharmacies. The Act, aimed at lowering prescription drug costs, has reportedly created challenges for pharmacies to maintain profitability, particularly in areas with high crime rates. This regulatory burden complicates the landscape, making it unfeasible for many pharmacies to operate sustainably.